Abstract
Objectives
To evaluate the effects of cartilage oligomeric matrix protein (COMP)- angiopoietin-1 (Ang1) on allogeneic islet graft survival in a bioinert perforated chamber.
Results
COMP-Ang1 treatment significantly decreased lipopolysaccharide-induced cell apoptosis and islet-related lymph node cell proliferation (both P < 0.01). Tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 levels in the chamber exudate were significantly lower in the COMP-Ang1 + chamber group than in the chamber group (all P < 0.05), as were the protein expression levels. COMP-Ang1 significantly inhibited the expression of Toll-like receptor 4 (TLR4) in cultured islets. Finally, full COMP-Ang1 treatment resulted in the longest survival time among the treatment groups.
Conclusion
Combined use of the bioinert perforated chamber with COMP-Ang1 is an effective strategy for improving islet allograft survival.
Similar content being viewed by others
References
Barton FB, Rickels MR, Alejandro R, Hering BJ et al (2012) Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 35:1436–1445
Brindle NP, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98:1014–1023
Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, Yasunaga K, Kim KT, Kim I, Choi HH, Kim W, Kim SH, Park SK, Lee GM, Koh GY (2004) COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101:5547–5552
Echavarria R, Mayaki D, Neel JC, Harel S, Sanchez V, Hussain SN (2015) Angiopoietin-1 inhibits toll-like receptor 4 signalling in cultured endothelial cells: role of miR-146b-5p. Cardiovasc Res 106:465–477
Fiorina P, Folli F, Bertuzzi F, Maffi P et al (2003) Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 26:1129–1136
Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro R (2005) Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5:2037–2046
Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87:603–607
Jiang J, Li J, Hao X, Diao J, Liu B, Xia W, Guo S (2012) Use of autologous chondrocytes and bioinert perforated chambers to tissue engineer cartilage in vivo. J Surg Res 173:e27–e32
Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86:952–959
Kim I, Moon SO, Park SK, Chae SW, Koh GY (2001) Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89:477–479
Koh GY (2013) Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 19:31–39
Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG (2005) Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105:1523–1530
Lysy PA, Weir GC, Bonner-Weir S (2012) Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med 1:150–159
Murugan R, Venkataraman R, Wahed AS, Elder M, Hergenroeder G, Carter M, Madden NJ, Powner D, Kellum JA, Investigators HIS (2008) Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med 36:1810–1816
Park KS, Shim EY, Choi BK, Moon C, Kim SH, Kim YS, Kwon CH, Joh JW, Koh GY, Kim SJ (2010) Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation. Transplant Proc 42:2653–2657
Salvalaggio PR, Deng S, Ariyan CE, Millet I, Zawalich WS, Basadonna GP, Rothstein DM (2002) Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74:877–879
Syrjala SO, Nykanen AI, Tuuminen R, Raissadati A, Keranen MA, Arnaudova R, Krebs R, Koh GY, Alitalo K, Lemstrom KB (2015) Donor heart treatment with COMP-Ang1 limits ischemia-reperfusion injury and rejection of cardiac allografts. Am J Transplant 15:2075–2084
Wang S, Hao X, Su Y, Yi C, Li B, Fan X, Pei J, Song Y, Xia W, Liu B, Guo S (2013) The utilization of perforated bioinert chambers to generate an in vivo isolated space for tissue engineering involving chondrocytes, mesenchymal stem cells, and fibroblasts. Tissue Eng Part C Methods 19:352–362
Zhou L, Yoon SJ, Jang KY, Moon YJ, Wagle S, Lee KB, Park BH, Kim JR (2014) COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats. Plos One 9:e110593
Funding
This work was supported by the Foundation of Xijing Hospital (XJZT13Z03) and the National Natural Science Foundation of China (81500450, L.N.J.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest concerning this article.
Additional information
Dalei Wang and Lina Jiang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wang, D., Jiang, L., Liang, Y. et al. COMP-Ang1 promotes long-term survival of allogeneic islet grafts in a bioinert perforated chamber by inhibiting inflammation via inhibition of the TLR4 signaling pathway. Biotechnol Lett 38, 1033–1042 (2016). https://doi.org/10.1007/s10529-016-2059-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-016-2059-6